|
Presentaciones Seleccionadas
"Multicomponent reactions with heterocycles. Modular access to privileged structures" (R. Lavilla, IRBB-PCB-UB, Barcelona).
"Prion diseases: overview and therapeutic approaches" (M. Gasset, Instituto Rocasolano-CSIC, Madrid).
"Safety in drug research: hERG channel inhibition" (Pedro Grima-Poveda; NV Organon, Oss, Holanda).
"DC-SIGN: a target for the design of new antiviral drugs" (Javier Rojo, IIQ-CSIC, Sevilla).
"Recent advances in drug delivery" (Begoña Carreño, Novartis, Basel).
"RNA interference: therapeutic potential of a biological revolution" (Juan Valcárcel, CRG, Barcelona).
"Fragment screening in drug discovery" (Marc Martinell, Crystax Pharmaceuticals, Barcelona).
"Carbohydrate-based strategies of antiviral therapeutics" (Jan Balzarini, Rega Institute, Lovaina).
"Hot topics in pharma patenting" (Neus Virgili, Palau Pharma SA, Barcelona).
"NMR in drug development" (Antonio Pineda, IIPF, Valencia).
[Inicio]
|